Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-08

Clinical Trial Update: A RCT of Triple Therapy With Proton Pump Inhibitor vs Vonoprazan for Helicobacter Pylori Gastritis [Phase 4]

View source ↗

Summary

Phase 4 randomized trial comparing triple therapy with a proton pump inhibitor versus vonoprazan for Helicobacter pylori infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Proton Pump Inhibitor + antibiotics triple therapy
  • Vonoprazan (vonoprazan)

Snippet

Sponsor: Changi General Hospital | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: UNKNOWN